Prevalence of obesity, type II diabetes mellitus, hyperlipidemia, and hypertension in the United States: Findings from the GE centricity electronic medical record database

Population Health Management

Volumn 13, Issue 3, 2010, Pages 151-161

  Crawford, Albert G ^a   Cote, Christine ^b   Couto, Joseph ^a   Daskiran, Mehmet ^b   Gunnarsson, Candace ^c   Haas, Kara ^d   Haas, Sara ^c   Nigam, Somesh C ^b   Schuette, Rob ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b JOHNSON AND JOHNSON   (United States)

^c S2 Statistical Solutions Inc   (United States)

^d ETHICON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC DISEASE; COMORBIDITY; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH SURVEY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT CODING; PREVALENCE; RACE DIFFERENCE; SEX DIFFERENCE; ADOLESCENT; AGE DISTRIBUTION; EPIDEMIOLOGY; ETHNIC GROUP; FACTUAL DATABASE; MEDICAL RECORD; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTOR; SEX RATIO; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BIAS (EPIDEMIOLOGY); BODY MASS INDEX; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; ELECTRONIC HEALTH RECORDS; ETHNIC GROUPS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; UNITED STATES;

EID: 77954173445     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2009.0039     Document Type: Article

References (23)

1. Reaven GM. Role of insulin resistance in human disease. The Banting lecture. Diabetes 1988;37:1595-1607.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
3. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999;16:442-443.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
5. Alberti K, Zimmet P, Shaw J. Metabolic syndrome-A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.
6. Lawlor D, Davey Smith GD, Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 2006;49:41-48.
7. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabet Care 2005;28:1769-1778.
8. Malik S, Nathan D, Wong S, et al.. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adult. Circulation 2004;110:1245-1250.
9. Meigs JB, Wilson PWF, Nathan DM, et al.. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003;52:2160-2167.
10. Hanley AJG, Karter AJ, Williams K, et al.. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: The insulin resistance atherosclerosis study. Circulation 2005;112:3713-3721.
11. Hong Y, Jin X, Mo J, et al.. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality. Results of prospective analysis for the atherosclerosis risk in communities study. J Intern Med 2007; 262:113-123.
12. Meigs JB, Rutter MK, Sullivan LM, et al.. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 2007;30:1219-1225.
13. Park Y, Shu S, Palianiappen L, et al.. The metabolic syndrome. Arch Int Med 2003;163:427-436.
14. National Heart, Lung, and Blood Institute and Boston University. Framingham heart study. Available at: http:// www.nhlbi.nih.gov/about/ framingham/index.html. Accessed December 12, 2007.
15. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli SP. An investigation of coronary heart disease in families: The Framingham Offspring Study. Am J Epidemiol 1979;110:281-290.
16. Bays HE, Chapman RH, Grandy S, for the SHIELD Investigators' Group. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract 2007;61:737-747.
17. McTigue K, Larson JC, Valoski A, et al.. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 2006;296:79-86.
18. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health 2007;121:492-496.
19. Brixner D, Said Q, Kirkness C, Oberg B, Ben-Joseph R, Oderda G. Assessment of cardiometabolic risk factors in a national primary care electronic health record database. Value in Health 2007;10:S29-S36.
20. Gill J, Chen Y. Quality of lipid management in outpatient care: A national study using electronic health records. Am J Med Qual 2008;23:375-381.
21. Oderda G, Brixner D, Lieberman M. Comparison of EMR data to US national data. Paper presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 10th Annual European Congress; October 20-23, 2007; Dublin, Ireland.
22. Grundy SM, Cleeman JI, Daniels SR, et al.. Management of the metabolic syndrome: An American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752.
23. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, and the National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003;289:2560-2572.